GO:0001671 ATPase activator activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001671 ATPase activator activity is a molecular function defined as binding to and increasing the activity of an ATP hydrolysis activity.
• ATPase activators are essential for energy metabolism, ion homeostasis, and muscle function, as shown by their role in calcium handling and ATPase stimulation [3,5].
• Key proteins with ATPase activator activity include SERCA1 (ATP2A1) and its activator MCARE, which enhances SERCA1 activity in fast-twitch muscle.
• Dysregulation of ATPase activator activity is linked to conditions such as sickle cell disease, heart failure, and aging-related muscle decline [2,3,4].
• Exercise and pharmacological interventions can modulate ATPase activator activity, offering therapeutic potential [1,4,6,7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to study the causal roles of ATPase activators in health and disease [5,8].
Description
ATPase activator activity (GO:0001671) is a molecular function that enhances the rate of ATP hydrolysis by binding to and stimulating an ATPase enzyme. This activity is critical for numerous cellular processes, including ion transport, muscle contraction, and energy metabolism [3,5]. Researchers study ATPase activators to understand how cells regulate ATP consumption and maintain homeostasis under physiological and pathological conditions [2,5]. For example, the cytoplasmic activator of the (Ca2++Mg2+)-ATPase in red blood cell membranes is essential for calcium homeostasis, and its dysfunction is associated with sickle cell disease. Similarly, MCARE has been identified as a direct activator of SERCA1 in fast-twitch muscle, where it maintains calcium handling and muscle integrity. These findings underscore the importance of ATPase activator activity in both basic biology and disease mechanisms.
ATPase activator activity At A Glance
| GO ID | GO:0001671 |
|---|---|
| GO term | ATPase activator activity |
| Ontology | molecular_function |
| Synonym | ATPase stimulator activity |
| Definition | Binds to and increases the activity of an ATP hydrolysis activity. |
| Major function | Enhances ATP hydrolysis by ATPases, regulating energy metabolism and ion transport. |
| Example proteins | MCARE (activator of SERCA1), red blood cell cytoplasmic activator of (Ca2++Mg2+)-ATPase |
| Related diseases | Sickle cell disease, heart failure, aging-related muscle weakness |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, biochemical ATPase assays |
What Is GO:0001671?
ATPase activator activity (GO:0001671) is defined as the molecular function of binding to an ATPase enzyme and increasing its ATP hydrolysis activity. This term is used to annotate proteins that stimulate ATPases, often through direct physical interaction, thereby modulating energy-dependent processes [3,5].
Why Is ATPase activator activity Important in Cell Biology?
ATPase activator activity is fundamental to cellular energy management and signaling because it directly controls the rate of ATP hydrolysis by ATPases, which are involved in ion pumping, muscle contraction, and metabolite transport [3,5]. Dysregulation of this activity can lead to impaired calcium handling, as seen in sickle cell membranes where decreased activation of the (Ca2++Mg2+)-ATPase contributes to disease pathology. Moreover, interventions such as aerobic exercise can modulate ATPase activator pathways, improving cardiac and skeletal muscle function [4,6,7]. Thus, understanding ATPase activator activity offers insights into both normal physiology and therapeutic strategies for metabolic and cardiovascular diseases.
• Regulates ATP hydrolysis, a central process in cellular energy metabolism.
• Controls calcium homeostasis through activation of Ca2+-ATPases like SERCA.
• Its dysfunction is linked to sickle cell disease due to decreased activation of (Ca2++Mg2+)-ATPase.
• Aerobic exercise can enhance ATPase activator signaling, improving heart failure outcomes.
• Aging is associated with altered ATPase activator function in muscle.
• Pharmacological activation of ATPases (e.g., by MCARE) may protect muscle integrity.
• V-ATPase assembly factors, which can act as activators, are involved in autophagy regulation.
• Mechanosensitive Piezo1 activation by exercise may influence ATPase-related pathways.
• Phosphorylase kinase ATPase activity is regulated in parallel with its kinase activity, highlighting crosstalk.
• Soybean isoflavones can modulate energy metabolism, potentially via ATPase activation.
What Happens During ATPase activator activity?
Binding of the activator to the ATPase
In simple terms: The activator protein attaches to the ATPase enzyme.
The first step in ATPase activator activity is the physical binding of the activator to its target ATPase. This interaction is often specific and can be regulated by cellular signals [3,5]. For example, the red blood cell cytoplasmic activator binds to the (Ca2++Mg2+)-ATPase, and this binding is required for increased ATP hydrolysis.
Conformational change and activation
In simple terms: Binding causes the ATPase to change shape and work faster.
Upon binding, the activator induces a conformational change in the ATPase that enhances its catalytic efficiency. This can involve stabilization of the active site or promotion of subunit assembly [5,6]. MCARE, for instance, enhances SERCA1 activity by stabilizing a conformation that favors calcium transport and ATP hydrolysis.
Increased ATP hydrolysis and downstream effects
In simple terms: The ATPase breaks down more ATP, leading to cellular effects.
The ultimate outcome of ATPase activator activity is an increased rate of ATP hydrolysis, which drives ion transport, muscle contraction, or other energy-dependent processes [3,5]. In fast-twitch muscle, MCARE-mediated activation of SERCA1 maintains calcium handling and prevents muscle damage.
Regulation by physiological stimuli
In simple terms: Exercise and other signals can turn activators on or off.
ATPase activator activity is not constant; it can be modulated by physiological stimuli such as exercise, hormones, and metabolic status [1,4,6,7]. Aerobic interval training improves cardiac function in heart failure patients, partly by enhancing ATPase-related pathways. Similarly, treadmill exercise activates Piezo1, which may influence ATPase activator signaling.
Key Genes Involved in GO:0001671 ATPase activator activity
The following genes and proteins are directly implicated in ATPase activator activity or serve as key ATPases whose activation is studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP2A1 (SERCA1) | Calcium-transporting ATPase in fast-twitch muscle | Target of activator MCARE; knockout models show muscle dysfunction |
| MCARE | Activator of SERCA1 | Enhances SERCA1 activity; knockout leads to impaired calcium handling |
| ATP2B1 (PMCA1) | Plasma membrane Ca2+-ATPase | Activator studies in calcium homeostasis |
| ATP1A1 (Na+/K+-ATPase) | Sodium-potassium ATPase | Potential target of activators in ion transport |
| VMA21 | V-ATPase assembly factor | Acts as activator of V-ATPase; linked to autophagy |
| PIEZO1 | Mechanosensitive ion channel | Exercise-induced activation may modulate ATPase pathways |
| PHKG1 | Phosphorylase kinase subunit | ATPase activity regulated in parallel with kinase activity |
| ADRB2 | Beta-2 adrenergic receptor | Mediates exercise-induced V-ATPase assembly factor signaling |
| APP | Amyloid precursor protein | Mutations affect autophagy-lysosomal flux via V-ATPase |
| PSEN1 | Presenilin 1 | Mutations impair V-ATPase assembly factor signaling |
| ATP2A2 (SERCA2) | Calcium ATPase in cardiac muscle | Target of activators in heart failure |
| ATP2B4 (PMCA4) | Plasma membrane Ca2+-ATPase | Potential activator target in calcium signaling |
| ATP6V1A | V-ATPase catalytic subunit | Activator-regulated assembly |
| ATP6V0A1 | V-ATPase subunit | Assembly factor VMA21 regulates its function |
| ATP5F1A | Mitochondrial ATP synthase subunit | Energy metabolism studies |
| ATP5F1B | Mitochondrial ATP synthase subunit | Energy metabolism studies |
| ATP2C1 | Secretory pathway Ca2+-ATPase | Potential activator target |
| ATP13A2 | Lysosomal ATPase | Neurodegeneration-related ATPase |
How Is ATPase activator activity Regulated?
ATPase activator activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and interaction with assembly factors. For instance, the V-ATPase assembly factor VMA21 is regulated by ADRB2/β2-adrenergic receptor signaling during exercise, which promotes V-ATPase assembly and function. Similarly, phosphorylase kinase ATPase activity is regulated in parallel with its protein kinase activity, suggesting coordinated regulation. Physiological stimuli such as aerobic exercise can enhance ATPase activator pathways, as seen in heart failure patients undergoing interval training. Additionally, soybean isoflavones affect energy metabolism in swimming mice, potentially through modulation of ATPase activities.
ATPase activator activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP2B1 | Sickle cell disease | Knockout or point mutation in erythroid cells |
| ATP2A1 | Heart failure, muscle weakness | MCARE knockout mouse |
| VMA21 | Alzheimer's disease | APP-PSEN1/PS1 mouse with VMA21 knockout |
| PIEZO1 | Myocardial infarction | Treadmill exercise mouse model with Piezo1 knockout |
| PHKG1 | Metabolic disorders | Phosphorylase kinase point mutation |
Sickle Cell Disease
In sickle cell disease, the (Ca2++Mg2+)-ATPase activity in red blood cell membranes shows decreased activation by the cytoplasmic activator, contributing to calcium dysregulation and disease pathology.
Heart Failure
Aerobic interval training improves cardiovascular function in heart failure patients, partly by enhancing ATPase activator signaling and calcium handling. MCARE-mediated activation of SERCA1 is critical for maintaining muscle integrity, and its dysfunction may exacerbate heart failure.
Aging and Muscle Weakness
Aging muscle exhibits altered ATPase activator function, leading to impaired energy metabolism and muscle weakness. Interventions that boost ATPase activator activity may mitigate age-related decline.
Neurodegeneration
Defects in V-ATPase assembly factor VMA21 signaling, which acts as an ATPase activator, impair autophagy-lysosomal flux and contribute to Alzheimer's disease pathology in APP-PSEN1/PS1 mice.
From ATPase activator activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MCARE impair SERCA1 activity? | MCARE knockout mouse |
| Does a point mutation in ATP2B1 affect activator binding? | CRISPR point mutation in erythroid cells |
| Can knock-in of a constitutively active ATPase activator improve heart function? | Knock-in mouse expressing active MCARE |
| What is the effect of VMA21 overexpression on autophagy? | Overexpression of VMA21 in APP-PSEN1/PS1 mice |
| Does Piezo1 activation by exercise require ATPase activator activity? | Piezo1 knockout mouse with treadmill exercise |
| How does phosphorylase kinase ATPase activity affect metabolism? | Phosphorylase kinase point mutation knock-in |
How to Study the ATPase activator activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ATPase assay | Rate of ATP hydrolysis | Quantifying activator stimulation |
| CRISPR knockout | Loss-of-function effects | Determining necessity of activator |
| CRISPR point mutation | Effect of specific amino acid changes | Mapping activator binding sites |
| Knock-in | Gain-of-function or tagged protein | Studying activator localization and function |
| Overexpression | Increased activator levels | Testing sufficiency in disease models |
| RNA-seq | Transcriptional changes | Identifying pathways regulated by activators |
| Proteomics | Protein abundance and modifications | Detecting activator interactions |
| Live-cell imaging | Dynamic calcium or ATP levels | Visualizing activator effects in real time |
Biochemical ATPase Assays
ATPase activity is typically measured using colorimetric or fluorometric assays that detect inorganic phosphate release from ATP. These assays can be used to quantify the stimulatory effect of activators on purified ATPases [3,5].
CRISPR-Cas9 Genome Editing
CRISPR knockout, point mutation, and knock-in models allow researchers to dissect the causal role of ATPase activators in cells and animals. For example, MCARE knockout mice reveal its essential role in SERCA1 activation.
Transcriptomics and Proteomics
RNA-seq and proteomics can identify changes in ATPase activator expression and post-translational modifications under different conditions, such as exercise or disease [1,6].
Live-Cell Imaging
Fluorescent reporters of ATP levels or calcium indicators can visualize the real-time effects of ATPase activator activity in living cells [5,7].
How CRISPR Can Be Used to Study GO:0001671 ATPase activator activity
Knockout
CRISPR knockout of ATPase activator genes, such as MCARE, can abolish activation of target ATPases, leading to impaired calcium handling and muscle dysfunction. Knockout models are essential for establishing the necessity of activators in physiological processes.
Point Mutation
Introducing point mutations in ATPase activator genes or their binding interfaces can reveal critical residues for interaction and activation. For example, mutations in the cytoplasmic activator of (Ca2++Mg2+)-ATPase may mimic the decreased activation seen in sickle cell disease.
Knock-in
Knock-in of tagged or constitutively active versions of ATPase activators allows for precise tracking and functional studies. Tagged MCARE knock-in mice can be used to study its localization and interaction with SERCA1 in vivo.
Overexpression
Overexpression of ATPase activators, such as VMA21, can enhance V-ATPase assembly and autophagy, offering a strategy to rescue autophagy-lysosomal deficits in neurodegeneration models.
How EDITGENE Supports ATPase activator activity Research
Researchers studying ATPase activator activity-related genes often need to determine whether a candidate gene is causally involved in a specific physiological or pathological process. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such studies, ensuring that every experiment is grounded in rigorous, publication-ready data.
Contact EDITGENE today to design your custom CRISPR model for ATPase activator activity research.
Frequently Asked Questions About ATPase activator activity
What is ATPase activator activity?
ATPase activator activity (GO:0001671) is a molecular function where a protein binds to an ATPase and increases its rate of ATP hydrolysis.
What genes are involved in ATPase activator activity?
Key genes include ATP2A1 (SERCA1), MCARE, ATP2B1, VMA21, and PIEZO1, among others [3,5,6,7].
How is ATPase activator activity measured?
It is typically measured using biochemical ATPase assays that detect inorganic phosphate release from ATP in the presence of the activator.
What diseases are associated with ATPase activator activity?
Diseases include sickle cell disease, heart failure, aging-related muscle weakness, and neurodegeneration [2,3,4,6].
Can exercise modulate ATPase activator activity?
Yes, aerobic exercise can enhance ATPase activator signaling, improving cardiac and skeletal muscle function [4,6,7].
What is the role of MCARE in ATPase activator activity?
MCARE is an activator of SERCA1 that enhances its calcium-transporting ATPase activity in fast-twitch muscle.
How does VMA21 act as an ATPase activator?
VMA21 is a V-ATPase assembly factor that promotes the assembly and activity of the V-ATPase complex, enhancing ATP hydrolysis.
What CRISPR models are available to study ATPase activator activity?
Knockout, point mutation, knock-in, and overexpression models can be generated to study the function of ATPase activators [5,8].
Is ATPase activator activity important for aging?
Yes, aging muscle shows altered ATPase activator function, contributing to impaired energy metabolism and muscle weakness.
How can I study ATPase activator activity in my lab?
You can use biochemical assays, CRISPR genome editing, transcriptomics, proteomics, and live-cell imaging to investigate ATPase activator activity [3,5,6].
Conclusion
ATPase activator activity (GO:0001671) is a critical molecular function that regulates ATP hydrolysis by ATPases, impacting energy metabolism, ion homeostasis, and muscle function [3,5]. Dysregulation of this activity is linked to diseases such as sickle cell disease, heart failure, and neurodegeneration [3,4,6]. Advances in CRISPR-based models and biochemical assays are enabling researchers to dissect the precise roles of ATPase activators and develop targeted therapeutic strategies [5,8]. Continued research into this function promises to uncover new insights into cellular physiology and disease mechanisms.
References
- 1. Deng BN et al.. 2018. [Effects of soybean isoflavones on the energy metabolism of swimming mice].. Zhongguo Ying Yong Sheng Li Xue Za Zhi 34(1):39-42 PMID: 29926657
- 2. Nair KS. 2005. Aging muscle.. Am J Clin Nutr 81(5):953-63 PMID: 15883415
- 3. Gopinath RM et al.. 1979. (Ca2++Mg2+)-ATPase activity of sickle cell membranes: decreased activation by red blood cell cytoplasmic activator.. Am J Hematol 7(4):303-12 PMID: 161856
- 4. Wisløff U et al.. 2007. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study.. Circulation 115(24):3086-94 PMID: 17548726
- 5. Sasaki T et al.. 2025. MCARE enhances SERCA1 activity in fast-twitch muscle to maintain calcium handling and muscle integrity.. Nat Commun 17(1):629 PMID: 41372236
- 6. Wu JJ et al.. 2024. Aerobic exercise attenuates autophagy-lysosomal flux deficits by ADRB2/β2-adrenergic receptor-mediated V-ATPase assembly factor VMA21 signaling in APP-PSEN1/PS1 mice.. Autophagy 20(5):1015-1031 PMID: 37964627
- 7. Duan X et al.. 2026. Treadmill exercise activates mechanosensitive Piezo1 to inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction in mice.. Basic Res Cardiol 121(1):77-91 PMID: 41400681
- 8. Paudel HK et al.. 1991. The ATPase activity of phosphorylase kinase is regulated in parallel with its protein kinase activity.. J Biol Chem 266(25):16524-9 PMID: 1832156
